MX2022009492A - Tratamiento de la menorragia en pacientes con enfermedad de von willebrand grave mediante la administración de factor de von willebrand (fvw) recombinante. - Google Patents
Tratamiento de la menorragia en pacientes con enfermedad de von willebrand grave mediante la administración de factor de von willebrand (fvw) recombinante.Info
- Publication number
- MX2022009492A MX2022009492A MX2022009492A MX2022009492A MX2022009492A MX 2022009492 A MX2022009492 A MX 2022009492A MX 2022009492 A MX2022009492 A MX 2022009492A MX 2022009492 A MX2022009492 A MX 2022009492A MX 2022009492 A MX2022009492 A MX 2022009492A
- Authority
- MX
- Mexico
- Prior art keywords
- von willebrand
- menorrhagia
- treatment
- patients
- administration
- Prior art date
Links
- 208000027276 Von Willebrand disease Diseases 0.000 title abstract 3
- 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 title abstract 3
- 208000007106 menorrhagia Diseases 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 108010047303 von Willebrand Factor Proteins 0.000 abstract 1
- 102100036537 von Willebrand factor Human genes 0.000 abstract 1
- 229960001134 von willebrand factor Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención hace referencia a un método para tratar la menorragia en un sujeto con enfermedad de von Willebrand (EVW) que comprende administrar una cantidad terapéutica de factor de von Willebrand recombinante (FVWr) al sujeto.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062969998P | 2020-02-04 | 2020-02-04 | |
| PCT/US2021/016592 WO2021158777A1 (en) | 2020-02-04 | 2021-02-04 | Treatment of menorrhagia in patients with severe von willebrand disease by administration of recombinant vwf |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022009492A true MX2022009492A (es) | 2022-11-09 |
Family
ID=74759563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022009492A MX2022009492A (es) | 2020-02-04 | 2021-02-04 | Tratamiento de la menorragia en pacientes con enfermedad de von willebrand grave mediante la administración de factor de von willebrand (fvw) recombinante. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230398188A1 (es) |
| EP (1) | EP4100048A1 (es) |
| JP (1) | JP2023514541A (es) |
| KR (1) | KR20220150303A (es) |
| CN (1) | CN115335074A (es) |
| AR (1) | AR121268A1 (es) |
| AU (1) | AU2021216945A1 (es) |
| BR (1) | BR112022015326A2 (es) |
| CA (1) | CA3169996A1 (es) |
| MX (1) | MX2022009492A (es) |
| TW (1) | TW202134266A (es) |
| WO (1) | WO2021158777A1 (es) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US3941763A (en) | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| US8597910B1 (en) | 1985-04-11 | 2013-12-03 | Children's Medical Center Corporation | DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells |
| JPS62502589A (ja) | 1985-04-11 | 1987-10-08 | ザ・チヤイルドレンズ・メデイカル・センタ−・コ−ポレ−シヨン | フオン・ビルブラント因子 |
| DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| AT405485B (de) | 1997-05-28 | 1999-08-25 | Immuno Ag | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
| AU2003291689A1 (en) | 2002-10-31 | 2004-05-25 | Protein Design Labs, Inc. | Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization |
| US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
| ES2434035T3 (es) | 2004-12-27 | 2013-12-13 | Baxter International Inc. | Conjugados de polímero-factor von Willebrand |
| ES2474573T3 (es) | 2006-01-04 | 2014-07-09 | Baxter International Inc | Medio de cultivo celular sin oligop�ptidos |
| JP5781931B2 (ja) | 2008-10-21 | 2015-09-24 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | 凍結乾燥した組換え型ｖｗｆ製剤 |
| ES2761692T5 (es) | 2010-07-08 | 2023-07-05 | Takeda Pharmaceuticals Co | Método de producción de vWF recombinante de alto peso molecular en cultivo celular |
| CN108210889A (zh) | 2011-06-10 | 2018-06-29 | 百深有限责任公司 | 通过施用重组vwf治疗凝血疾病 |
-
2021
- 2021-02-04 MX MX2022009492A patent/MX2022009492A/es unknown
- 2021-02-04 WO PCT/US2021/016592 patent/WO2021158777A1/en unknown
- 2021-02-04 AR ARP210100294A patent/AR121268A1/es unknown
- 2021-02-04 CA CA3169996A patent/CA3169996A1/en active Pending
- 2021-02-04 KR KR1020227030129A patent/KR20220150303A/ko unknown
- 2021-02-04 TW TW110104257A patent/TW202134266A/zh unknown
- 2021-02-04 CN CN202180023624.3A patent/CN115335074A/zh active Pending
- 2021-02-04 BR BR112022015326A patent/BR112022015326A2/pt unknown
- 2021-02-04 AU AU2021216945A patent/AU2021216945A1/en active Pending
- 2021-02-04 US US17/759,992 patent/US20230398188A1/en active Pending
- 2021-02-04 EP EP21708526.5A patent/EP4100048A1/en active Pending
- 2021-02-04 JP JP2022547192A patent/JP2023514541A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023514541A (ja) | 2023-04-06 |
| CN115335074A (zh) | 2022-11-11 |
| KR20220150303A (ko) | 2022-11-10 |
| AR121268A1 (es) | 2022-05-04 |
| AU2021216945A1 (en) | 2022-09-01 |
| CA3169996A1 (en) | 2021-08-12 |
| EP4100048A1 (en) | 2022-12-14 |
| WO2021158777A1 (en) | 2021-08-12 |
| US20230398188A1 (en) | 2023-12-14 |
| TW202134266A (zh) | 2021-09-16 |
| BR112022015326A2 (pt) | 2022-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20170056T2 (hr) | Terapija male učestalosti glatiramer acetatom | |
| ES2193159T3 (es) | Una formulacion de factor de coagulacion viii. | |
| MX2015012175A (es) | Tratamiento de la deficiencia de la hormona del crecimiento pediatrica con analogos de la hormona del crecimiento humano. | |
| RU2015116264A (ru) | Композиции и способы лечения сердечной недостаточности у пациентов с диабетом | |
| AR086904A1 (es) | Tratamiento de trastornos de la coagulacion por medio de la administracion de factor recombinante de von willebrand (vwf) | |
| RU2014127298A (ru) | Применения иммуноконъюгатов, мишенью которых является cd138 | |
| MX2022000430A (es) | Administracion de agonista de sting e inhibidores de puntos de control. | |
| MX2022009492A (es) | Tratamiento de la menorragia en pacientes con enfermedad de von willebrand grave mediante la administración de factor de von willebrand (fvw) recombinante. | |
| MY193963A (en) | Composition for treating joint diseases and kit containing same | |
| JOP20190019A1 (ar) | تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH) | |
| CO2020001314A2 (es) | Tratamiento de pacientes con enfermedad de von willebrand grave que se someten a cirugía electiva mediante administración de vwf recombinante | |
| RU2016138790A (ru) | Композиции на основе сиалированных гликопротеинов и их применение | |
| CO2020001322A2 (es) | Tratamiento de hemorragia gastrointestinal en pacientes con enfermedad de von willebrand grave mediante la administración de vwf recombinante | |
| JOP20170044B1 (ar) | تركيبة صيدلانية تشتمل على hgh ناتج عن عودة الارتباط الجيني لعلاج نقص هرمون النمو | |
| BR112023022195A2 (pt) | Novas composições e métodos de n,n-dimetiltriptamina | |
| US20200237780A1 (en) | Preservative-free Treprostinil Devices | |
| JP2020526525A5 (es) | ||
| CO2021011340A2 (es) | Métodos de tratamiento profiláctico con vwf recombinante (rvwf) | |
| RU2710541C1 (ru) | Способ лечения ангулярного хейлита, возникшего вследствие дефицита рибофлавина | |
| US10835553B2 (en) | Application of hydroxypropyl methyl cellulose in preparation of medicine for treatment of esophageal mucosa | |
| YUTSKOVSKAYA et al. | Neck and chest | |
| Yutskovskaya et al. | Neck and chest: MesoCaHA for cheeks, neck, and décolletage | |
| AR118608A2 (es) | TRATAMIENTO DE LOS TRASTORNOS DE LA COAGULACIÓN MEDIANTE LA ADMINISTRACIÓN DE UN FACTOR DE VON WILLEBRAND (vWF) RECOMBINANTE | |
| UA135348U (uk) | Спосіб лікування хронічного некалькульозного холециститу у хворих із супутнім цукровим діабетом типу 2 | |
| RU2015147544A (ru) | Пролонгированный фактор эритропоэза человека и лекарственное средство на его основе |